Annual D&A
N/A
December 31, 2024
Summary
- ADMA annual depreciation & amortization is not available.
Performance
ADMA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
December 31, 2024
Summary
- ADMA quarterly depreciation & amortization is not available.
Performance
ADMA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
December 31, 2024
Summary
- ADMA TTM depreciation & amortization is not available.
Performance
ADMA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
ADMA Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ADMA Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
ADMA Biologics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.94 M(-5.2%) | $8.21 M(-1.8%) |
| Jun 2024 | - | $2.05 M(-3.2%) | $8.36 M(-0.6%) |
| Mar 2024 | - | $2.11 M(+0.2%) | $8.41 M(+1.0%) |
| Dec 2023 | $8.33 M(+17.1%) | $2.11 M(+0.8%) | $8.33 M(+2.1%) |
| Sep 2023 | - | $2.09 M(-0.3%) | $8.16 M(+2.9%) |
| Jun 2023 | - | $2.10 M(+3.2%) | $7.93 M(+4.9%) |
| Mar 2023 | - | $2.03 M(+5.0%) | $7.56 M(+6.2%) |
| Dec 2022 | $7.11 M(+29.4%) | $1.94 M(+4.0%) | $7.11 M(+6.2%) |
| Sep 2022 | - | $1.86 M(+8.0%) | $6.69 M(+7.0%) |
| Jun 2022 | - | $1.72 M(+8.4%) | $6.25 M(+6.8%) |
| Mar 2022 | - | $1.59 M(+4.7%) | $5.86 M(+6.6%) |
| Dec 2021 | $5.50 M(+39.4%) | $1.52 M(+6.8%) | $5.50 M(+5.5%) |
| Sep 2021 | - | $1.42 M(+7.3%) | $5.21 M(+8.0%) |
| Jun 2021 | - | $1.33 M(+7.8%) | $4.82 M(+10.0%) |
| Mar 2021 | - | $1.23 M(-0.2%) | $4.38 M(+11.2%) |
| Dec 2020 | $3.94 M(+21.0%) | $1.23 M(+19.0%) | $3.94 M(+11.4%) |
| Sep 2020 | - | $1.04 M(+16.9%) | $3.54 M(+6.5%) |
| Jun 2020 | - | $885.70 K(+12.3%) | $3.32 M(+2.5%) |
| Mar 2020 | - | $788.80 K(-4.8%) | $3.24 M(-0.5%) |
| Dec 2019 | $3.26 M(-5.5%) | $828.60 K(+1.3%) | $3.26 M(-2.8%) |
| Sep 2019 | - | $818.10 K(+1.5%) | $3.35 M(-0.9%) |
| Jun 2019 | - | $806.10 K(+0.1%) | $3.38 M(-1.2%) |
| Mar 2019 | - | $805.30 K(-12.8%) | $3.42 M(-0.7%) |
| Dec 2018 | $3.45 M | $923.90 K(+9.1%) | $3.45 M(-13.5%) |
| Sep 2018 | - | $847.10 K(+0.1%) | $3.98 M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $845.90 K(+2.0%) | $3.97 M(+16.7%) |
| Mar 2018 | - | $829.50 K(-43.2%) | $3.40 M(+26.4%) |
| Dec 2017 | $2.69 M(+473.3%) | $1.46 M(+74.7%) | $2.69 M(+99.5%) |
| Sep 2017 | - | $836.10 K(+201.7%) | $1.35 M(+114.0%) |
| Jun 2017 | - | $277.10 K(+134.6%) | $630.40 K(+34.3%) |
| Mar 2017 | - | $118.10 K(+0.2%) | $469.30 K(-0.1%) |
| Dec 2016 | $469.60 K(-0.0%) | $117.90 K(+0.5%) | $469.60 K(+0.1%) |
| Sep 2016 | - | $117.30 K(+1.1%) | $468.90 K(-0.1%) |
| Jun 2016 | - | $116.00 K(-2.0%) | $469.50 K(-0.3%) |
| Mar 2016 | - | $118.40 K(+1.0%) | $471.10 K(+0.3%) |
| Dec 2015 | $469.80 K(+89.5%) | $117.20 K(-0.6%) | $469.80 K(+4.5%) |
| Sep 2015 | - | $117.90 K(+0.3%) | $449.40 K(+16.5%) |
| Jun 2015 | - | $117.60 K(+0.4%) | $385.70 K(+21.8%) |
| Mar 2015 | - | $117.10 K(+21.0%) | $316.70 K(+27.8%) |
| Dec 2014 | $247.90 K(+17.7%) | $96.80 K(+78.6%) | $247.90 K(+22.3%) |
| Sep 2014 | - | $54.20 K(+11.5%) | $202.70 K(-0.3%) |
| Jun 2014 | - | $48.60 K(+0.6%) | $203.40 K(-5.6%) |
| Mar 2014 | - | $48.30 K(-6.4%) | $215.40 K(+2.2%) |
| Dec 2013 | $210.60 K(+15.7%) | $51.60 K(-6.0%) | $210.70 K(+5.1%) |
| Sep 2013 | - | $54.90 K(-9.4%) | $200.40 K(+3.1%) |
| Jun 2013 | - | $60.60 K(+39.0%) | $194.40 K(+8.1%) |
| Mar 2013 | - | $43.60 K(+5.6%) | $179.90 K(-1.2%) |
| Dec 2012 | $182.10 K | $41.30 K(-15.5%) | $182.00 K(+29.4%) |
| Sep 2012 | - | $48.90 K(+6.1%) | $140.70 K(+53.3%) |
| Jun 2012 | - | $46.10 K(+0.9%) | $91.80 K(+100.9%) |
| Mar 2012 | - | $45.70 K | $45.70 K |
FAQ
- What is the all time high annual D&A for ADMA Biologics?
- What is the all time high quarterly D&A for ADMA Biologics?
- What is the all time high TTM D&A for ADMA Biologics?
What is the all time high annual D&A for ADMA Biologics?
ADMA Biologics all-time high annual depreciation & amortization is $8.33 M
What is the all time high quarterly D&A for ADMA Biologics?
ADMA Biologics all-time high quarterly depreciation & amortization is $2.11 M
What is the all time high TTM D&A for ADMA Biologics?
ADMA Biologics all-time high TTM depreciation & amortization is $8.41 M